Wolverine Trading
IGC icon

Wolverine Trading’s IGC Pharma IGC Stock Holding History

Wolverine Trading’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,200
Closed -$4.42K – 5064
2024
Q2 		$4.42K Buy
+10,200
New +$5.07K ﹤0.01% 4370
2023
Q3 		– Sell
-14,800
Closed -$4.71K – 4776
2023
Q2 		$4.71K Buy
14,800
+800
+6% +$259 ﹤0.01% 4156
2023
Q1 		$5K Sell
14,000
-56,800
-80% -$21.3K ﹤0.01% 4101
2022
Q4 		$23K Buy
70,800
+1,000
+1% +$408 ﹤0.01% 3714
2022
Q3 		$32K Buy
69,800
+17,900
+34% +$9.54K ﹤0.01% 4279
2022
Q2 		$28K Sell
51,900
-39,300
-43% -$24.8K ﹤0.01% 4184
2022
Q1 		$91K Buy
91,200
+36,100
+66% +$35.1K ﹤0.01% 4860
2021
Q4 		$55K Sell
55,100
-26,300
-32% -$35.3K ﹤0.01% 5299
2021
Q3 		$120K Sell
81,400
-73,200
-47% -$118K ﹤0.01% 5674
2021
Q2 		$241K Buy
+154,600
New +$236K ﹤0.01% 4757
2021
Q1 		– Sell
-27,900
Closed -$47K – 6113
2020
Q4 		$47K Buy
+27,900
New +$41.2K ﹤0.01% 4616
2020
Q3 		– Sell
-10,400
Closed -$8K – 4814
2020
Q2 		$8K Sell
10,400
-1,100
-10% -$596 ﹤0.01% 4466
2020
Q1 		$6K Buy
+11,500
New +$6.38K ﹤0.01% 4504

Other funds holding IGC

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
DP
Dearborn Partners Chicago, Illinois $1.85B AUM 6.59% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wolverine Trading's IGC Position: Q3 2025 in Review

Wolverine Trading opened a new position in IGC Pharma (IGC) in Q3 2025: 18,479 shares worth $7.76K. The stake represents ﹤0.01% of the portfolio and ranks #5561 among its holdings. This is a return to the name: Wolverine Trading previously reported a position in IGC as recently as Q4 2021.

Wolverine Trading first reported a position in IGC in Q3 2021 and has held it in 3 quarters since. The position peaked at $20K in Q3 2021. 35 funds tracked by Wall St. Rank hold IGC as of Q3 2025.

  • Wolverine Trading held 18,479 shares of IGC Pharma worth $7.76K as of Q3 2025.
  • IGC Pharma was a new Wolverine Trading position in Q3 2025.
  • IGC Pharma made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #5561 holding.
  • Wolverine Trading first reported a position in IGC Pharma in Q3 2021 and has held it in 3 quarters since.
  • Wolverine Trading's IGC Pharma position peaked at $20K in Q3 2021.
  • 35 funds tracked by Wall St. Rank held IGC Pharma as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.